Previous Page  15 / 20 Next Page
Information
Show Menu
Previous Page 15 / 20 Next Page
Page Background

Page 49

conferenceseries

.com

Volume 7

Journal of Infectious Diseases & Therapy

Infectious Diseases & Endocrinology 2019

February 27-28, 2019

February 27-28, 2019 Tokyo, Japan

Infectious Diseases, Diabetes and Endocrinology

Global Experts Meeting on

J Infect Dis Ther 2019, Volume 7

DOI: 10.4172/2332-0877-C2-063

Psychosis in a hypothyroid: Is it really myxedema madness?

Mehvish Khan

USA

S

ymptoms of hypothyroidismmostly revolve aroundmetabolic slowing. Neuropsychological symptoms referred to asmyxedema

madness can be found in 5-15% of myxedematous patients who have had total thyroidectomy, Hashimoto’s thyroiditis

or in patients non-compliant to medication. The association has been well described in some studies however the treatment

options remain controversial. Despite the known association between hypothyroidism and psychosis, identification of a primary

psychotic disorder maybe missed. A 71-year-old-male with history of depression, Post-Traumatic Stress Disorder (PTSD) and

Hashimoto’s disease presented with psychosis and bizarre behavior including belligerence for five months. Review of systems

was negative. There was no known family history of psychiatric illness. Social history was positive for smoking. His prescribed

medications included Clonazepam, Ambien and Armor thyroid which he was non-compliant to for over one year. Physical

exam on admission revealed depressed mood, monotonous speech, disorganized thought process with flight of ideas, auditory

hallucinations, poor motivation and insight. Urine toxicology was negative. Liver, metabolic and kidney functions were normal.

Thyroid stimulating hormone was 89.9 mIU/ml, free thyroxine 0.25 ng/ml, free triiodothyronine 1.8 pg/ml, thyroid peroxidase

antibody 103 IU/ml, anti-thyroglobulin antibody 34 IU/mL. Computed tomography of the head showed no acute findings. A

diagnosis of myxedema psychosis was established and he was initiated with levothyroxine. The rest of his home medications were

continued. Patient’s psychosis improved in the next four days and he was discharged. He returned to the emergency room two

days later with worsening auditory and visual hallucinations. He was then started on risperidone along with prazosin for PTSD.

By day ten, his speech remained monotonous, thought process was disorganized and tangential. Insight remained poor however

he no longer had auditory hallucinations or delusions. During his admission, records discovered at home revealed that he had

an established diagnosis of schizophrenia, paranoid type which had been untreated for over twenty years. Once hypothyroidism

is identified, delusions and hallucinations that characterize myxedema madness tend to remit in about one week of appropriate

thyroid hormone supplementation. In this case, symptoms took a turn for the worse. Initiation of atypical antipsychotics at a low

dose has appeared to be well tolerated. Psychiatric complaints in a known hypothyroid patient maybe misdiagnosed and labeled

as neuroendocrine which may lead to delay in treatment for functional psychotic disorders. This case illustrates the importance

of implementing antipsychotic treatment in an atypical presentation of a common medical condition.

mehv.khan9@gmail.com